Journal of Molecular Biochemistry

In July 2011 LIP issued the first CALL FOR PAPERS, for the Journal of Molecular Biochemistry. JMedBiochem is planned to proceed as a monthly publication, issuing one volume per year. We encourage all scientists in the broad area of Molecular Biochemistry to consider our Journal for publishing their work. Please visit us at: It is the vision of LIP to publish high quality research articles in the area of Molecular Biochemistry. We strongly believe that the open access publishing model will promote research and knowledge across the globe, since academics, researchers and students are provided with unrestricted access to high interest research articles.
The Journal of Molecular Biochemistry is an open access journal that provides rapid publication of articles in all areas relevant to the subject of molecular biochemistry. Topics & Scope: Molecular Biochemistry, Molecular Modelling, Bioinformatics, Drug Design, Quantum Mechanics, Virology, Medicinal Chemistry, Biological Evaluation of Enzymatic Assays, Molecular Biology, Stem Cell Research, Regenerative Medicine, Developmental Biology, Cell Signalling. The Journal of Molecular Biochemistry is serving the novel aim of worldwide unrestricted access to research publications. JMolBiochem is an open access journal and supports the Open Access Initiative (OAI) in academic publishing. We believe that subscription-based journals constrain the flow of scientific knowledge by limiting the visibility and impact of published works. Indexing and retrieval of all scientific papers is top priority. JMB is under PubMed monitoring and has been issued a partial 2015 IF of 3.21

Dr Dimitrios P. Vlachakis, Editor-in-Chief

Lorem Ipsum Press ltd

Dr Dimitrios Vlachakis is the owner and founder of the Lorem Ipsum Press (LIP) publishing company.
LIP is dedicated to Open Access Academic Publishing. LIP aims to publish novel and pioneering research work and findings of high scientific interest. It is our goal to provide a fast, effortless and costless service for publishing academic work. We offer a fast reviewing system that guarantees quick publication (six weeks) of the article, which will immediately be listed on our online archive for retrieval and reference purposes.LIP furthers the scientific society’s objective of excellence in academia, research, and education by open access publishing worldwide.
Lorem Ipsum Press ™ (LIP) is an open access academic publisher. LIP strongly supports the open access movement and believes that information should be freely accessible to all. All journal articles will be published under the terms of the Creative Commons Attribution License allowing unrestricted copying, distribution, transmission and adaptation of the work, under the condition that the original article is properly cited. More specifically, authors who publish with LIP agree to the following terms: •Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal. •Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. •Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published material.

Dr Dimitrios P. Vlachakis, CEO & Founder